Canary Speech is a series a startup. 1 investor tracked. Status: possibledead.
Canary Speech is a startup founded in 2018 based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Canary Speech develops AI-powered voice biomarker technology to screen for mental health and neurological disorders through real-time vocal analysis, enabling early detection of conditions like depression, anxiety, and cognitive impairments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.